SCHEMBL23902889

SCHEMBL23902889

CC(C)n1nc2ncnc-2c(N)n1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PI4KB Q9UBF8 12/20 0.35
ADORA2A P29274 3/20 0.35
ADORA1 P30542 3/20 0.35
ADORA2B P29275 2/20 0.35
PI4KA P42356 1/20 0.35
PI4K2B Q8TCG2 1/20 0.35
PI4K2A Q9BTU6 1/20 0.35
SRC P12931 14/20 0.35
ABL1 P00519 13/20 0.35
EGFR P00533 12/20 0.35
HCK P08631 12/20 0.35
KDR P35968 12/20 0.35
PIK3CB P42338 12/20 0.35
MTOR P42345 12/20 0.35
PIK3CG P48736 12/20 0.35
EPHB4 P54760 12/20 0.35
PRKDC P78527 12/20 0.35
PIK3CD O00329 11/20 0.35
PIK3CA P42336 11/20 0.35
TOP2A P11388 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23902886 0.75 ADORA2A (0.33) PI4KBADORA2AADORA1ADORA2BPI4KA
SCHEMBL18076608 0.63 NPC1 (0.33) PI4KBADORA2AADORA1ADORA2BPI4KA
SCHEMBL19522164 0.59 ADORA2A (0.50) PI4KBADORA2AADORA1ADORA2BPI4KA
SCHEMBL24670253 0.57 TOP2A (0.38) TOP2A
SCHEMBL18076633 0.57 AAK1 (0.37)
SCHEMBL23902965 0.56 PI4KB (0.39) PI4KBADORA2AADORA1ADORA2BPI4KA
SCHEMBL1914 0.55 ADORA2A (0.41) ADORA2AADORA1
SCHEMBL10261918 0.55 SRC (0.66) PI4KBSRCABL1EGFRHCK
SCHEMBL23869924 0.55 KDR (0.56) PI4KBADORA2AADORA1ADORA2BPI4KA
SCHEMBL12616367 0.53 TOP2A (0.37) TOP2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210309688-A1 PRMT5 INHIBITORS MERCK SHARP & DOHME CORP. (US) 2021-10-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210309688-A1 PRMT5 INHIBITORS PRMT5, PRMT1, PRMT6 PI4KB 3092/4885ADORA2A 4256/4885ADORA1 3850/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.